Modulation of interstitial collagenase in scleroderma and normal fibroblasts

European Journal of Dermatology

Volumn 6, Issue 8, 1996, Pages 555-562

  Ueberham, Uwe ^a   Ueberham, Elke ^b   Haustein, Uwe Frithjof ^a   Herrmann, Konrad ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Institute of Biochemistry   (Germany)

Author keywords

Collagenase; Fibroblast; S stemic sclerosis; TGF ; Tnf a

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; SCLERODERMA;

EID: 0030477760     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro. J Clin Invest 1974; 54: 880-9.
2. Rodnan GP, Lipinski I, Luksick J. Skin collagen content in progressive systemic sclerosis (scleroderma) and localized scleroderma. Arthritis Rheum 1979; 22: 130-40.
3. Scharffetter K, Lankat-Buttgereit B, Krieg T. Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest 1988; 18: 9-17.
4. Peltonen J, Kähäri L, Jaakkola S, Kanari V-M, Varga J, Uitto J, Jimenez SA. Evaluation of transforming growth factor- and type I procollagen gene expression in fibrotic skin disease by in situ hybridization. J Invest Dermatol 1990; 94: 365-71.
5. Herrmann K, Heckmann M, Kulozik M, Haustein U-F, Krieg T. Steady-state mRNA levels of collagen I, III, fibronectin, and collagenase in skin biopsis of systemic sclerosis patients. J Invest Dermatol 1991 ; 97: 21 9-22.
6. Brady AH. Collagenase in scleroderma. J Clin Invest 1975; 56: 1175-80.
7. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collage-nose expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103:359-63.
8. Uitto J, Bauer EA, Eisen AZ. Scleroderma. Increased bio-synthesis of triplehelical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts. J Clin Invest 1979; 64: 921-30.
9. Ignotz RA, Massague J. Transforming growth factor- stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-42.
10. Van Obberghen-Schiiling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor l positively regulates its own expression in normal and transformed cells. J Biol Chem 1988; 263: 7741-6.
11. Gabrielli A, Di Lorento C, Taborro R, Candela M, Sambo P, Nitti C. Immunohistochemical localization of intracellular and extracellular associated TGF- in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. Clin Immunol Immunopathol 1993; 68: 340-9.
12. Gruschwitz M, Müller PU, Sepp N, Hofer E Fontana A, Wick G. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 1990; 94: 197-203.
13. Kulozik M, Hogg A, Lankat-Buttereit B, Kreig T. Co-localization of transforming growth factor-2 with aljl) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990; 86: 917-22.
14. McWhirter A, Colosetti P, Rubin K Miyazano K. Black C. Collagen type I is not under autocrine control by transforming growth factor-l in normal and scleroderma fibroblasts. Laboratory Investigation 1994; 71: 885-94.
15. Ota H, Kumagai S, Morinobu A, Yanagida H, Nakao K. Enhanced production of transforming growth factor-beta [TGF-) during autologous mixed lymphocyte reaction of systemic sclerosis patients. Clin Exp Immunol 1995; 100:99-103.
16. Kantor TB, Friberg D, Medsger TA, Buckingham TB, Whiteside TL. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopafho/1992:65: 278-85.
17. Fleiscnmajer R, Perlish JS, Reeve JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977; 20: 975-84.
18. Umehara H, Kumagai S, Murakami M, Suginoshita T, Tanaka K, Hashida S, Ishikawa E, Imura H. Enhanced production of interleukin-1 and tumor necrosis factor a by cultured peripheral blood monocytes from patients with scleroderma. Arthritis Rheum 1990; 33: 893-7.
19. Sykes B, Puddle B, Francis M Smith R. The estimation of two collagens from human dermis by interrupted gel electrophoresis. Biochem Biophys Res Comm 1976; 72: 1472-80.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, 1989.
21. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987; 47: 5616-9.
22. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assojan RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor-beta complementary DMA sequence and expression in normal and transformed cells. Nature 1985; 316: 701-5.
23. Ito A, Sato T, Iga T, Mori Y. Tumor necrosis factor bifunctionally regulates matrix metalloproteinase and tissue inhibitor of metalloproteinase (TIMP) production by human fibroblasts. FEBS Lett 1990; 269: 93-5.
24. Rapala KT, Vähä-Kreula MO, Heino JJ, Vuorio El. Laato MK. Tumor necrosis factor-a inhibits collagen synthesis in human and rat granulation tissue fibroblasts. Expérimenta 1996; 52: 70-4.
25. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M. Prolonged activation of iun and collaqenase qenes by tumor necrosis factor-a. Nafure 1989; 337:661.
26. Takeda K, Hatamochi A, Arakawa M, Ueki H. Effects of tumor necrosis factor-a on connective tissue metabolism in normal and scleroderma fibroblast cultures. Arch Dermatol Res 1992; 284: 440-4.
27. Perlish JS, Bashey Rl, Stephans RE, Fleischmajer R. Connective tissue synthesis of cultured scleroderma fibroblasts. I. In vitro collagen synthesis by normal and scleroderma fibroblasts. Arthritis Rheum 1976; 19: 891-901.
28. Krieg T, Luderschmidt C, Weber L, Müller PK, Braun-Falco O. Scleroderma fibroblasts: some aspects of in vitro assessment of collagen synthesis. Arch Dermatol Res 1981; 270: 263-72.
29. Katayama K, Seyer JM, Raghow R, Kang AH. Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide. Biochemistry 1991 ; 30: 7097-104.
30. Pacini A, Gardi C, Corradeschi F, Viti A, Belli C, Calzoni P. In vivo stimulation of lung collagen synthesis by collagen derived peptides. Res Commun Chem PatholPharmacol 1990; 68: 89-101.
31. Gardi C, Pacini A, de Santi MM, Calzoni P, Viti A, Corradeschi F. Development of interstitial lung fibrosis by long-term treatment with collagen breakdown products in rabbits. Res Commun Chem Pathol Pharmacol 1990; 68: 235-50.
32. Falanga V, Zhou LH, Takagi H, Murata H, Oschoa S, Martin TA, Helfman T. Human dermal fibroblast clones derived from single cells are heterogenous in the production of mRNAs for al(l) procollagen and transforming growth factor-β1 J Invest Dermatol 1995; 105: 27-31.
33. Mauch C, Adelmann-Grill B, Hatamochi A, Krieg T. Collagenase gene expression in fibroblasts is regulated by a three dimensional contact with collagen. FEBS Lett 1989; 250: 301.